Ecnoglutide delivers 35% greater weight loss than semaglutide in head-to-head study
June 08, 2026 | 09:46
Sciwind Biosciences has announced head-to-head study data showing its new-generation biased GLP-1 ecnoglutide delivered 35% greater weight loss than semaglutide in patients with metabolic disease.
Latest News
Mobile Version